Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
British Journal of Haematology|April 16, 2026
Chimeric antigen receptor T cells for autoimmune diseases, in particular immune thrombocytopeniaSamuel P Soff, Samuel Ruder, James B BusselUrologic Oncology|February 25, 2026
Cell-surface targets for prostate cancer therapeuticsSamuel Ruder, Pardis Ziaeefar, Ambika P Jaswal, et al.Current Opinion in Urology|January 23, 2025
Antibody-drug conjugates in urothelial carcinoma: current status and futureSamuel Ruder, Juana Martinez, Jessica Palmer, et al.Current Treatment Options in Oncology|March 26, 2025
Advances in PSMA-Targeted Radionuclide TherapeuticsSamuel Ruder, Andres Ricaurte-Fajardo, Michael Sun, et al.Human Pathology|December 30, 2023
Quantification of collagen content and stromal cellularity within reactive stroma is predictive of prostate cancer biochemical recurrence and specific deathYi Ding, Ping Bu, Binara Assylbekova, et al.European Urology|June 16, 2019
Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysisScot A Niglio, Rachel Jia, Jiayi Ji, et al.Human Pathology|February 17, 2022
Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosisSamuel Ruder, Yan Gao, Yi Ding, et al.Pageof 1